Cannabis Use Disorder Treatment — Evidence-Based Options

There are no FDA-approved medications for cannabis use disorder, but evidence-based behavioral treatments work well. VA offers cognitive behavioral therapy, motivational enhancement therapy, and contingency management (operating at 100+ VA medical centers with over 90% abstinence rates in verified samples). You do not need to stop using cannabis before starting PTSD treatment.

What Works

Evidence-based CUD treatment includes CBT, MET, contingency management, and Seeking Safety for comorbid PTSD. No FDA-approved medications exist for CUD. VA offers all of these treatments free. Abstinence is not required before PTSD treatment — you can address both simultaneously.

Cognitive Behavioral Therapy (CBT) for CUD

CBT is the most researched treatment for cannabis use disorder. It typically involves:

Functional analysis — identifying situations, thoughts, and feelings that trigger cannabis use
Coping skills training — developing non-cannabis strategies for managing triggers
Behavioral experiments — testing new responses to high-risk situations
Relapse prevention — planning for high-risk periods and developing responses
Cognitive restructuring — addressing thinking patterns that sustain use

Typical duration: 8–12 individual sessions or 8–12 group sessions. Research shows CBT produces modest but meaningful reductions in cannabis use and associated problems, with effects lasting beyond the treatment period.

Motivational Enhancement Therapy (MET)

MET is a brief, focused intervention based on motivational interviewing principles. It helps veterans:

Explore their ambivalence about cannabis use
Develop their own motivation for change
Commit to specific goals
Plan for implementing change

Typical duration: 4 sessions. MET is often combined with CBT (sometimes called MET-CBT) for additive effect. It is particularly effective for veterans who are not yet fully committed to reducing or stopping use, because it meets people where they are rather than assuming readiness.

Contingency Management — The VA's Strongest Tool

Contingency management (CM) is a prize-based incentive program where veterans earn prizes or vouchers for verified abstinence (typically confirmed by urine drug screens). CM is rooted in behavioral conditioning principles and has one of the strongest evidence bases of any addiction treatment.

VA operates a contingency management program at 100+ VA medical centers with:

Over 6,300 veterans treated since 2011
Over 82,000 urine samples collected
Over 90% of samples testing negative

This is one of the most effective CUD interventions documented in any healthcare system. If contingency management is available at your VA facility, it is typically the first-line behavioral treatment for cannabis use disorder. Ask your VA SUD team whether it is available where you are.

Seeking Safety — For Comorbid PTSD and CUD

Seeking Safety is an integrated treatment designed specifically for people with co-occurring PTSD and substance use disorder. It is present-focused (not trauma-processing) and emphasizes:

Safety as the priority across physical, emotional, and relational domains
Integrated treatment of trauma and substance use together
Coping skills that address both PTSD symptoms and substance use triggers
Case management to address practical life problems

Seeking Safety has a strong evidence base for veterans with combat PTSD and substance use disorder. It is often appropriate for veterans who are not yet ready for trauma-focused psychotherapy (PE, CPT, EMDR) but who need to address both problems.

Medications — Limited Options

There are no FDA-approved medications for cannabis use disorder. This is in contrast to:

Alcohol use disorder: naltrexone, acamprosate, disulfiram are FDA-approved
Opioid use disorder: buprenorphine, methadone, naltrexone are FDA-approved
Tobacco use disorder: varenicline, bupropion, nicotine replacement therapies

Off-label candidates being studied include:

N-acetylcysteine (NAC): A modified amino acid with some evidence for CUD in adolescents; limited evidence in adults
Gabapentin: Some evidence for reducing cannabis use during withdrawal
FAAH inhibitors: Experimental; would theoretically support endocannabinoid tone during withdrawal
CBD: Small trials suggest potential benefit; not FDA-approved for CUD

VA providers may prescribe these medications off-label for specific patients, but none is standard CUD treatment.

Cannabis Withdrawal Management

Cannabis withdrawal is real and can make the first 1–3 weeks of abstinence particularly difficult. Symptoms include:

Irritability, anger, aggression
Anxiety, restlessness
Sleep difficulty, strange/vivid dreams (REM rebound)
Decreased appetite, weight loss
Depressed mood
Physical symptoms: headaches, sweating, chills, tremors, abdominal pain

Most withdrawal symptoms peak at 2–6 days after cessation and resolve over 1–3 weeks. For veterans with comorbid PTSD, withdrawal can temporarily worsen PTSD symptoms (particularly sleep and hyperarousal), which is one reason why many veterans return to cannabis use during the difficult initial weeks.

Approaches for managing withdrawal:

Gradual reduction rather than sudden cessation, if possible
Behavioral support through CBT or contingency management during the high-risk early period
Sleep interventions (CBT-I, sleep hygiene) to address the REM rebound
Short-term medication for severe symptoms (e.g., gabapentin for sleep/anxiety, non-addictive options for GI symptoms)
Social support and harm reduction for lapses, recognizing that many veterans have multiple attempts before sustained abstinence

Harm Reduction as an Alternative to Abstinence

For veterans who are not ready or not willing to achieve full abstinence, harm reduction is a legitimate goal. Reducing cannabis use, shifting to lower-risk products, reducing frequency, avoiding combinations with other substances, and improving timing can all meaningfully reduce harms without requiring complete abstinence. Lower-risk use guidelines.

What to Expect from VA SUD Treatment

VA SUD treatment is:

Free (covered under standard VA care)
Confidential under 38 U.S.C. § 7332
Non-punitive — treatment is not a path to disciplinary action
Evidence-based — VA SUD programs follow established clinical practice guidelines
Integrated with mental health care for comorbid conditions
Voluntary — you are not required to participate if you do not want to

Getting Started

Talk to your VA primary care provider about cannabis use and your interest in treatment
Request a referral to VA SUD services or general mental health
Ask specifically about contingency management if you are interested — availability varies by facility
If you have comorbid PTSD, ask about Seeking Safety or integrated trauma-SUD treatment
Be honest about your goals — whether that is abstinence, reduction, or just understanding your use better